Jazz Pharmaceuticals (JAZZ) Competitor Comparison
We are evaluating the key criteria listed to compare Jazz Pharmaceuticals (JAZZ) against its competitors in the Biotechnology industry.
Market Capitalization
22 / 368Gross Profits
5 / 278Total Revenue
4 / 300EBITDA
3 / 337Free Cashflow
3 / 352Quick Ratio
313 / 357Earnings per Share
5 / 359Dividend yield
0 / 6Total Cash
13 / 358Performance 3 years
100 / 368Performance 5 years
135 / 368Performance 10 years
121 / 368Linearity 3 years
5 / 368Linearity 5 years
21 / 368Linearity 10 years
42 / 368Total Rank
29 / 368Dividend Rank
174 / 368Valuation Rank
14 / 368Piotroski Rank
212 / 368Muliplier Rank
40 / 368Free Cashflow - JAZZ ranking 3 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.